indridi benediktsson dr. indridi benediktsson health research dg research – european commission...
TRANSCRIPT
Indridi Benediktsson
Dr. Indridi BenediktssonHealth Research
DG Research – European Commission
March 2008
International cooperation in the EU Framework Programmes
Health research
Indridi Benediktsson
Why research at European level?
Pooling and leveraging resources To achieve critical mass Complement private investments Interoperability and complementarity
Fostering capacity and excellence in S&T Stimulate training, mobility and career development of
researchers Improve S&T capabilities Stimulate competition in research
Better integration of European R&D Scientific base for pan-European policy Coordination of national policies Comparative research at EU-level Dissemination of research results
Indridi Benediktsson
The role of the EC in research
Funding agency Supporting research done by multi-national,
multi-disciplinary teams in pre-defined areas through FPs
Objective: to strengthen the S+T basis to increase competitiveness of industry and raise international standing of Europe
Preparing + implementing policies European Research Area, 3% of GDP for R&D,
European Patent, EMEA, TPs etc.
Indridi Benediktsson
Linking scientific and policy interests
The policy level needs to know what issues can and should be tackled by science
The scientists must formulate their future vision to fit the needs of society, if they want a greater share of the taxpayer’s money
EC acts as translator between the two “worlds”
Decision power lies with the EP and Council (MS)
Local policy makers need input from local scientific teams in order to support (or not) suggestions from the EC
The role of the EC in research
Indridi Benediktsson
EC programmes bring down barriers between countries:
multinational consortia researchers from any country in the world can participate coordination among national funding programmes
between different types of organizations: universities, research centres, SMEs, large companies, etc.
between disciplines: focus on interdisciplinary and translational research
and encourage mobility: Marie Curie fellowships for researchers and for host institutes, including ingoing & outgoing grants
The role of the EC in research
Indridi Benediktsson
FP7 Health
Main policy drivers: Improving health of European citizens
Increasing competitiveness of European health-related industries and businesses
Addressing global health issues, e.g. emerging epidemics
Budget: €6 billion over 7 years (2007-2013)
Indridi Benediktsson
Health research in FP7
Pillar 1:Biotechnology,
generic tools and medical
technologies for human
health
Pillar 2:Translating research for
human health
Pillar 3:Optimising the delivery
of health care to European
citizens
Funding schemes targeted at International Cooperation: SICA
Health of the Ageing population
Child Health
Funding schemes targeted at Small and Medium-sized Enterprises
Indridi Benediktsson
1: Biotechnology, generic tools and technologies
High-throughput research (enhancing data generation, standardisation, acquisition & analysis).
Detection, diagnosis and monitoring (with emphasis on non-invasive or minimally invasive approaches).
Innovative therapeutic approaches and interventions(with potential application in many diseases and disorders).
Predicting suitability, safety and efficacy of therapies
Collaborative researchin Health
Indridi Benediktsson
2: Translating research for human health
Integrating biological data and processes: (large-scale data gathering, systems biology)
Research on the brain and related diseases, human development and ageing
Infectious diseases: (antimicrobial drug resistance, HIV/AIDS, malaria, TB, emerging epidemics)
Other major diseases: (cancer, cardiovascular disease, diabetes/obesity; rare diseases; and other chronic diseases)
Collaborative researchin Health
Indridi Benediktsson
3: Optimising the delivery of health care
Enhanced health promotion and disease prevention
Translating clinical research into clinical practice
Quality, solidarity and sustainability of health systems
Collaborative researchin Health
Indridi Benediktsson
International Collaboration
-issues at stake:A) Development assistance
policy objectives, e.g. Millennium Development Goalstargets: low income countries, e.g. ACP
B) Strengthening competitiveness collaboration for mutual gainscompetition between the industrialised countries (e.g. attracting excellence)targets: more developed countries (e.g. BRIC)
C) Science diplomacycollaborating w. industrialised countries“ice breaking” when collaborating w. new partner countriesputting “flesh on the bones” of S+T agreementstargets: OECD, all 3rd countries
-All in the context of Excellence
Indridi Benediktsson
1. All activities open for International Cooperation1. All activities open for International Cooperation International Cooperation Partner Countries (ICPCs) can participate in projects and receive
EC funding as in FP6 Industrialised countries may be funded if their participation is seen as essential for the project Minimum number of participants: 3 from MS/AS
International Cooperation
in FP73 different avenues:
2. Specific International Cooperation Actions2. Specific International Cooperation Actions Address specific issues that partner countries face or have a global
character, on the basis of mutual interest and benefit Minimum number of participants: 2+2 (2 from MS/AS + 2 from ICPCs)
3. Bilateral agreements for targeted co-funding3. Bilateral agreements for targeted co-funding Individual agreements with specific countries (CN, RU…)
Indridi Benediktsson
International Cooperation
in FP7 Health
Programme level cooperation
In large scale In large scale projectsprojects where tasks can be divided where tasks can be divided Funding agencies and scientists design the “Meta”-project – agreeing on broad common principles Each agency issues calls according to own rules Projects are funded and required to work together Otherwise no contractual link
Indridi Benediktsson
Programme level cooperation with the USA - examples
• International Knock – out Mouse Consortium (IKMC) (2007) (EUCOMM – EU, KOMP – Canada, NORCOMM – USA)
• Human Metagenomics Consortium (in prep.) 2008 (EC, NIH, Japan? …)
• International Cancer Genomics Consortium (ICGC) (in prep.) (EC, Genome Canada, NIH...)
• “ Affinity Reagents for Human Proteome ” (in prep. – first meeting in Stockholm, March 2008)
Indridi Benediktsson
3rd Country Participation
in FP6 Health
In total: 214 participants from 51 third countriescommitted budget: 30 million Euro
Number of participants (if 5 or more)
0
5
10
15
20
25
30
35
China
RussiaUSA
Australia
Canada
South A
frica
Argentin
a
Ukrain
eIn
dia
Brazil
Kenya
Serbia
Number of 3rd country participants in FP6 Health projects
Indridi Benediktsson
3rd Country Participationin FP7 Health: 1st call 2007
Number of participants (if 5 or more)
Number of 3rd country participants in FP7 Health proposals
0
5
10
15
20
25
30
35
40
USA
Russia
China
South A
frica
India
Australia
Canada
Egypt
Argentin
a
Ukrain
e
Viet N
amJa
pan
Tanza
nia
In total: 263 participants from 54 third countries
0
5
10
15
20
25
30
35
40
USA
Russia
China
South A
frica
India
Australia
Canada
Egypt
Argentin
a
Ukrain
e
Viet N
amJa
pan
Tanza
nia
Indridi Benediktsson
3rd Country Participationin FP7 Health: 1st call 2007
Number of successful participants (if more
than 1)
Number of 3rd country participants in successful FP7 Health proposals
0
1
2
3
4
5
6
7
US
Russia
ChinaIn
dia
South
Afri
ca
Argenti
na
Colombia
Austra
lia
Canada
Viet N
am
Tanza
nia
Thaila
nd
In total: 60 participants from 30 third countries
Indridi BenediktssonIn total: 800 participants from 91 third countries
Health theme Outcome of 2nd call
Number of 3rd country participants in proposals (if ≥20)
0
20
40
60
80
100
120
India
China
USA
Brazil
Russi
a
Argen
tina
Egypt
S-Afri
ca
Colom
bia
Tunisi
a
Indridi Benediktsson
Number of participants in successful proposals (if ≥4)
Health theme Outcome of 2nd call
In total: 172 participants from 52 third countries
0
5
10
15
20
25
30
India
USA
China
Austra
lia
S-Afri
ca
Canad
a
Russi
a
Argen
tina
Brazil
Viet N
am
Indridi Benediktsson
Africa; 2,7
E-Asia; 2,1
N-Am; 1,7S-Asia; 1,7
S-Am; 1,5
SE-Asia; 1,5
EECA; 1,4
Other; 0,7
Geographical distribution of committed funds for non associated 3rd countries (million €)
First call 2006; total: 13.3 million, or 2.1% of the call budget
Indridi Benediktsson
Africa; 8,4
S-Asia; 6
N-Am; 4,1
S-Am; 4
SE-Asia; 3,9
EECA; 2,5
E-Asia; 1
Other; 0,8
Geographical distribution of committed funds for non associated 3rd countries (million €)
Second call 2007; total: 30.7 million, or 5.4% of the call budget
Indridi Benediktsson
0
1
2
3
4
5
6
7
8
9
Argentin
a
Brazil
Colom
bia
Mex
ico
Uruguay
Chile
Ecuad
or
Bolivia
Peru
Guatem
ala
Venez
uela
CSA-SA
CP-SICA
CP-FP
Health theme Results of first two calls
Nu
mb
er o
f p
arti
cip
ants
Indridi Benediktsson
Health theme Results of first two calls
Nu
mb
er o
f p
arti
cip
ants
0
10
20
30
40
50
60
70
80
90
100
Coll Res SICA CA+SA
other ICPC
Lat. Am.
Indridi Benediktsson
International Collaboration
in FP7 - HealthThe contextHEALTH is a political priority for most
countries in the world; industrialised, emerging economies and low income countries
Infectious diseases do not respect borders and can spread worldwide
“Rich world” diseases (cancer, diabetes…) also affect the developing countries and vice versa (Aids, TB…)
Treatments and cures are universal
Indridi Benediktsson
Timeframe for FP7 projects
20122006 2007 20142008 2009 2010 20152011 2013 2016
Official duration of FP7 2007-2013
Projects resulting from FP7 calls operating
Results from FP7 projects in use
Last projects startFirst projects startFirst calls Last projects end
2017 2018 2019 2020 2021
Indridi Benediktsson
How can EULARINET help?
in priority setting
– Centralise WP input from the region– Take stock of existing strengths
– No need to focus only on SICAs– Timing is important– Close involvement of relevant RTD units– Extensive argumentation
– No guarantee
Indridi Benediktsson
Contacts in the Health Directorate
Acting Director –Manuel [email protected]
Medical and Public Health Research – [email protected]
Public Health sector – [email protected]
Infectious Diseases – [email protected]
Genomics and Systems Biology – [email protected]
Health Biotechnology – [email protected]
Coordination – [email protected]
Indridi Benediktsson
Contacts & Information
Innovative Medicines Initiative (IMI)[email protected]://ec.europa.eu/research/health/imi/index_en.html
SME participation: [email protected]
International Cooperation: [email protected]
Framework Programme 7: http://cordis.europa.eu/fp7
Experts: http://cordis.europa.eu/research_openings
Indridi Benediktsson
Information
• EU research: http://ec.europa.eu/research
• Seventh Framework Programme: http://ec.europa.eu/research/fp7
• Information on research programmes and projects:
http://cordis.europa.eu/
•
http://ec.europa.eu/research/research-eu/
• Information requests: http://ec.europa.eu/research/enquiries/
Indridi Benediktsson
EC money
≠
Easy money